{"id":"NCT00963508","sponsor":"Sun Pharmaceutical Industries, Inc.","briefTitle":"Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice","officialTitle":"A Multi-Center Phase III Study to Evaluate Malathion Gel 0.5% Formulation, for the Control of Head Lice in Pediatric Subjects and Adult Subjects With Pediculosis Capitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-08","primaryCompletion":"2010-03","completion":"2010-03","firstPosted":"2009-08-21","resultsPosted":"2014-06-13","lastUpdate":"2014-06-13"},"enrollment":403,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Pediculosis"],"interventions":[{"type":"DRUG","name":"Malathion gel 0.5%","otherNames":[]},{"type":"DRUG","name":"Permethrin 1% rinse (Nix Crème)","otherNames":[]}],"arms":[{"label":"Malathion Gel","type":"EXPERIMENTAL"},{"label":"Nix Crème Rinse","type":"ACTIVE_COMPARATOR"}],"summary":"In this study, Malathion Gel 0.5% will be compared to Nix (permethrin 1%) as a treatment for head lice in patients 2 years of age and older. Malathion Gel 0.5% is a new formulation of an established head lice treatment. The new formulation has been evaluated in 2 previous studies of patients 2 years of age and older.","primaryOutcome":{"measure":"Proportion of Index Subjects Free of Any Lice 14 Days After Their Last Treatment in the Modified ITT (LOCF)","timeFrame":"3 weeks","effectByArm":[{"arm":"Malathion Gel","deltaMin":86.67,"sd":null},{"arm":"Nix Crème Rinse","deltaMin":45.33,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":4},"locations":{"siteCount":7,"countries":["United States"]},"refs":{"pmids":["17845167"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":206},"commonTop":["APPLICATION SITE PRURITUS","APPLICATION SITE ERYTHEMA","APPLICATION SITE EROSION","APPLICATION SITE IRRITATION","CONJUNCTIVAL IRRITATION"]}}